Introduction
Most experts recommend improving the predictive power of mutagenicity tests by developing more accurate in vitro models (1, 2) . The single culture models commonly used for in vitro genotoxicity assays cannot adequately mimic the absorption and metabolic processes that occur in vivo. However, the development of in vitro methods to reduce the use of laboratory animals is encouraged in several regulations (i.e. REACH) and supported by various instances (i.e. ECVAM). However the predictivity of in vitro tests for evaluating carcinogenicity potential should be improved (1) . In 2008, the International Workshop on Genotoxicity Testing (IWGT) held in Basel, Switzerland, highlighted the need for developing new in vitro models (3) . Conventional in vitro genotoxicity tests entail a single cell line and include the use of induced rat liver S9 fractions to mimic in vivo metabolism. However, this rodent alternative does not fully reproduce human metabolism or the complex interactions between organs, including intestinal transport and first-pass metabolism.
A three-dimensional model mimicking the properties of human skin (barrier function, metabolism) has been recently developed to study the genotoxic potential of chemicals applied to the skin (4) . This co-culture system includes reconstructed human skin cultured on membrane inserts with the mouse lymphoma L5178Y cell line growing underneath. Apical treatment with mitomycin-C, cyclophosphamide or apigenin induces micronucleus formation in the L5178Y cells, suggesting that this model can be useful for studying the genotoxicity of compounds that come in contact with the epidermis.
Similarly, more sophisticated models are needed to investigate the in vitro genotoxic potential of oral drugs and food contaminants. Before entering the systemic circulation, most orally administrated xenobiotics must pass through the intestinal barrier to reach the liver via the portal vein (5) . Intestinal first-pass metabolism, along with cytochrome P450 3A4 and multidrug efflux transporters such as P-gp, actively participate in the presystemic elimination of oral drugs (6) . Therefore, intestinal cells may bioactivate promutagen coumpounds into genotoxic metabolites, and upon systemic distribution induce DNA damage not only in enterocytes but also in blood cells and in other organs. We thus propose here a co-culture system involving differentiated human intestinal Caco-2 cells and lymphoblastoid TK6 cells. The Caco-2 cells can differentiate and form a monolayer with the same morphological and biochemical characteristics as human small intestine enterocytes (7). Because they also express various phase-1 and -2 enzymes and transporter proteins (e.g. CYP1A1, 1B1, SULT1A1 and 1A3, p-glycoprotein and MRP) (8) (9) (10) (11) , these cells may also be a suitable model to study xenobiotic metabolism. The P53-competent human TK6 cells are commonly used in genotoxicology testing as a target blood cell model for the micronucleus assay and in the thymidine kinase (TK) gene-mutation assay (12) (13) (14) .
In this study, we investigated the genotoxic potential of two promutagen compounds (BaP and AFB1) and a direct alkylating agent (MMS) on the Caco-2/TK6 co-culture system by using the comet and the micronucleus assays.
Materials and methods

Chemicals
Aflatoxin B1 (AFB1, Cas 1162-65-8), benzo[a]pyrene (BaP, Cas 50-32-8) and ketoconazole (Cas 65277-42-1) were purchased from Sigma (St. Quentin-Fallavier, France). Methylmethanesulfonate (MMS, Cas 66-27-3) was purchased from Acros Organics (Geel, Belgium).
Caco-2/TK6 co-culture system
The Caco-2 cell line was obtained from the American Type Culture Collection (ATCC N°HTB37) and was used between passages 30 and 40. The cells were maintained in modified Eagle's medium (MEM) containing glutamax TM , 10% fetal calf serum (FCS), 1% nonessential amino acids, penicillin (100 U/ml) and streptomycin (100 mg/ml) in a humidified atmosphere of 95% air and 5% CO 2 at 37°C. Cells (80% confluence) were split and seeded at 0.175 × 10 6 cells/cm². The human TK6 lymphoblastoid cell line was a gift from the Institut Pasteur in Lille (Fabrice Nesslany). The cells were maintained in tissue culture flasks with RPMI 1640 medium (Gibco) containing glutamax TM and supplemented with 10% FCS, 100 IU/ml of penicillin and 100 µg/ml of streptomycin.
For the co-culture studies, Caco-2 cells were seeded at 6 × 10 4 cells/cm 2 on polycarbonate membrane inserts (0.4 µm pore diameter, 12 mm insert, A co-culture system of human intestinal Caco-2 cells and lymphoblastoid TK6 cells for investigating the genotoxicity of oral compounds 12-well plate; Corning, USA). The culture medium was changed three times a week. After 25-27 days post-seeding, the monolayers of differentiated Caco-2 cells were used for co-culture experiments. Only the monolayers expressing a transepithelium electrical resistance (TEER) of approximately 700 Ω/cm², as measured with a Millicell-ERS system (Millipore), were kept for subsequent experiments. Just before treatment, 1.5 ml of RPMI glutamax medium with 5% FCS containing 1 × 10 5 TK6 cells was added to the basal (BL) side of the monolayer.
Chemical treatments
Chemicals were loaded by adding 0.5 ml of MEM medium without FCS to the apical (AP) side. Concomitant treatment with ketoconazole was done by adding 10 µM of ketoconazole to the AP side of the monolayer where AFB1 treatment was applied.
Comet assay
After 24 or 48 h of treatment, Caco-2 cells were trypsinised and TK6 cells were harvested. After centrifugation (2 min, 136 ×g), the cell pellets were suspended in a prewarmed low melting point agarose [0.5% in phosphate buffered saline (PBS)] and spread on conventional microscope slides (initially dipped in 1% agarose and dried) precoated with normal agarose (0.8% in PBS). The slides were then put in a lysis solution (2.5 M NaCl, 0.1 M EDTA, 10 mM Tris-HCl at pH 10 with extemporal addition of 10% DMSO and 1% Triton X-100), for 1 h at around 5°C. DNA was allowed to unwind for 40 min in electrophoresis buffer (0.3 M NaOH, 1 mM EDTA, pH 13) prior to electrophoretic migration (0.7 V/cm, 300 mA) for 24 min at room temperature. The slides were incubated twice for 5 min in a neutralising solution (0.4 M Tris-HCl, pH 7.5) and dried for storage with 95% ethanol for 5 min. DNA was stained with propidium iodide (2.5 µg/ml in PBS) just before examining the slide with a fluorescence microscope (Leica DMR) equipped with a CCD-200E video camera. At least two slides per dose and 100 cells per slide were analyzed using Comet Assay IV software (Perceptive Instruments, Haverhill, UK). The percentage of DNA in the comet tail (% tail DNA) was used to evaluate the extent of DNA damage.
Micronucleus assay on Caco-2 cells
The procedure described is in accordance with OECD guideline No. 487 for the in vitro mammalian cell micronucleus test with some modifications for differentiated Caco-2 cells as previously described (15, 16) .
At 25-27 days post-seeding in 12-well plates, differentiated Caco-2 cells were treated for 24 h. After treatment, cells were trypsinised and seeded to trigger proliferation at 29 × 10 3 cells/cm² in 6-well plates. After 40 h, cytochalasin B (4.5 µg/ml) was added for 30 h in culture medium with 10% FCS. Then, the cells were washed twice with PBS and allowed to recover for 1.5 h in a fresh 10% FCS medium. Finally, the cells were incubated in a hypotonic solution, centrifuged and fixed with methanol:acetic acid (3:1 v:v) for 15 min, prior to spreading on slide and staining with acridine orange.
All slides were scored blindly. The criteria for identifying micronuclei were those recommended by the HUMN project (17) .
Micronuclei were scored in 2000 binucleated cells from duplicate wells. Cytotoxicity was determined from 100-RI, where RI is the replication index, calculated as recommended (18) 
Micronucleus assay on TK6 cells
Following co-culture treatment, TK6 cells were harvested from the BL side, centrifuged and resuspended in RPMI medium. After a second centrifugation, the cell pellets were treated 4 min with a hypotonic solution (RPMI medium and distilled water 1:1, v:v). The cells were fixed with methanol-acetic acid (3:1, v:v) for 10 min at room temperature. Following centrifugation, the cells were resuspended with a few microlitres of the fixative solution, spread on microscope slides and stained with acridine orange.
Micronuclei were scored in 2000 intact mononucleated cells per culture and three independent assays were performed. Cytotoxicity was determined from the relative increase in cell count (RICC) as recommended (19) : 
Statistical analysis Comet assay.
Results from cell cultures subjected to different treatment conditions were tested for statistical significance using Dunnett's test for pairwise comparisons. Treatment means were considered significantly different at P < 0.05. Micronucleus assay. The percentages of micronucleated cells in treated and untreated solvent controls were compared using the one-way Pearson chi-square test. Treatment means were considered significantly different at P < 0.05. Figure 1 illustrates the Caco-2/TK6 co-culture system. The integrity of the Caco-2 cell monolayers was determined by measuring TEER before and after treatment. In fact, it is important to ensure that the compounds applied on the apical side of the model did not reach the basal side without a passage by the Caco-2 monolayer. TEER values after treatment with MMS, BaP and AFB1 were similar to those of control cultures indicating that monolayer integrity was not damaged due to chemical treatments, then a direct transfer of the chemicals to the basal compartment could be excluded (data not shown). Fig. 1 . Genotoxicity assay on a human co-culture cell system: the Caco-2/TK6 co-culture system. DNA damage was investigated using the comet and micronucleus assays on human intestinal cells (Caco-2 cells) and on TK6 cells, which represent the blood compartment. This system integrates both the metabolism and the transport capacities of Caco-2 cells.
Results
Caco-2/TK6 co-culture system
MMS
The clastogenic compound MMS at 10 µg/ml induced significant DNA damages in Caco-2 cells. Comet tail intensity (40%) increased dramatically compared with the solvent control (10%) (Figure 2) , as did the percentage of micronucelated cells (8.54% compared with 4% in the solvent control) (Table I ). In the TK6 cells seeded on the BL side, apical loading of MMS also induced micronuclei after 24 and 48 h of exposure, (1.03% and 2.63%, respectively, compared with 0.49% and 0.56%, respectively, for the solvent control) (Table II) .
BaP
BaP up to 5 µM showed DNA breaks in the comet assay on differentiated Caco-2 cells after 24 and 48 h of treatment ( Figure 2) . A dose-dependent increase of micronuclei (6.2% Fig. 2 . Caco-2/TK6 co-culture system: induction of DNA damage in Caco-2 and TK6 cells measured using the comet assay 24 and 48 h after apical loading with BaP and AFB1. DNA damage is expressed as the mean of median values of % tail DNA intensity from three independent experiments (±SEM). *P < 0.05 compared with control (Dunnett's test). and 12.6% micronucleated cells for 0.5 and 5 µM BaP, respectively) was also observed in Caco-2 cells after 24 h of treatment (Table I) . Cytotoxicity assessed using the micronucleus assay showed that BaP was highly cytotoxic at 10 µM with 59% cytostasis.
No comet formation was observed in the dividing TK6 cells on the BL side of the system following apical loading with BaP even after a 48 h (Figure 2) . A slight increase in micronucleated TK6 cells was observed after 48 h of exposure, but only had statistical significance at 10 µM, with 0.83% micronucleated cells (Table II) .
AFB1
Apical loading of AFB1, between 1 and 25 µM, did not induce any comet formation on either Caco-2 or TK6 cells, even after 48 h exposure (Figure 2 ). However, a large increase in micronuclei was observed in both cell lines. After 24 h of treatment, 6.5% and 20.8% micronucleated cells were scored in Caco-2 cells for 0.5 and 5 µM AFB1, respectively. However, cytotoxicity increased up to 55% at 10 µM (Table II) .
Chromosome damages were also induced on TK6 cells, 24 and 48 h after treatment. After 24 h, only the highest dose of AFB1, 25 µM, statistically increased the frequency of TK6 micronucleated cells (1.09% compared to the solvent control, 0.49%) (Table II) . After 48 h, cytostasis and the percentage of micronucleated TK6 cells increased dose-dependently with AFB1 up to 1 µM (Table II) , reaching 37% cytostasis and 2.26% micronuclei for the highest dose (Table II) .
Concomitant apical treatment with AFB1 and ketoconazole, a CYP450 3A inhibitor
To demonstrate that some biotransformation processes taking place within the Caco-2 cells may be involved in the induction of micronuclei in TK6 cells, a 48 h concomitant treatment of AFB1 (5-25 µM) with 10 µM ketoconazole, a CYP3A4 inhibitor, was conducted. Micronucleus formation and cytotoxicity induced by low doses of AFB1 in TK6 cells were completely inhibited (Table III ). Even though a low level of cytotoxicity and genotoxicity were still observed at 5 and 10 µM AFB1, differences between the values from treated and untreated samples were only slight. Accordingly, while 5 µM AFB1 induced 1.64% micronucleated TK6 cells and 28% cytotoxicity, the addition of 10 µM ketoconazole decreased the frequency of micronucleated cells to 0.75% (0.44% for the control), and cytotoxicity dropped to 6.41%. For the highest dose of AFB1 (25 µM), although ketoconazole clearly attenuated the effect of AFB1, the levels of cytotoxicity and micronuclei in TK6 cells were higher than in the solvent controls: the cytotoxicity decreased from 46% to 17% and the percentage of micronucleated cells from 2.5% to 1.0% without and with ketoconazole, respectively (Table III) .
Discussion
Considering the role of intestinal first-pass metabolism in the genotoxicity response of ingested compounds, we investigated the feasibility of a co-culture system of intestinal Caco-2 cells and lymphoblastoid TK6 cells to test the predictive genotoxicity of ingested compounds. Caco-2 cells, differentiated on membrane culture inserts, were chosen because they display the morphological and biochemical characteristics of human 44model for intestinal metabolism and transport studies *P < 0.05, **P < 0.01, ***P < 0.001, compared with corresponding control (Pearson's chi-square test). *P < 0.01, **P < 0.001, versus corresponding control (Pearson's chi-square test). (20) (21) (22) . The present study showed positive results with progenotoxic compounds, BaP and AFB1, suggesting that a bioactivation process occured in Caco-2 cells by cytochromes P450 phase I enzymes. However, comparing the CYP450 activities in differentiated Caco-2 cells and human enterocytes would support this hypothesis. Induction with omeprazol could improve the Caco-2 model for mimicking human gut metabolism especially by increasing the expression of the major intestinal CYP4503A4 (23) . Dividing TK6 cells were selected to mimic the blood compartment and target cells of toxic metabolites produced by enterocytes. This co-culture system gave unexpected results on the behavior of promutagens; promutagens were bioactivated by Caco-2 cells into genotoxic metabolites which, after transfer to the basal compartment, were brought in contact with the TK6 target blood cells. This model for investigating genotoxicity of ingested compounds is similar to the three-dimensional skin human model developed to investigate the safety of cosmetic products (4) .
After apical loading, the clastogenic compound MMS induced comet and micronucleus formation in Caco-2 cells, whereas only micronucleus formation was shown in TK6 cells. The absence of comet assay positive results in TK6 cells could suggest that primary DNA damages generated by MMS were either repaired or transformed into micronuclei after cell division.
Using the comet assay and the micronucleus test on differentiated Caco-2 cells, we found that BaP-induced primary DNA damage. Metabolic activation of BaP by CYP1A1 and CYP1B1 formed the ultimate reactive species, benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide (BPDE), producing DNA adducts (24) . We demonstrated for the first time that BaP also induces micronuclei on differentiated Caco-2 cells. We can suspect that Caco-2 cells metabolise BaP into genotoxic metabolites in agreement with reported CYP1A1 and 1B1 expression and genotoxicity (25) (26) (27) (28) (29) . Interestingly, in our co-culture system Caco-2/TK6, there was no DNA damage in TK6 cells after apical loading of BaP. These results suggest that BaP is bioactivated into genotoxic metabolites by Caco-2 cells but that these metabolites had not been transported to the BL side. BaP metabolism studies on Caco-2 monolayers indicate that a greater amount of BaP metabolites are detected on the AP side than on the BL side, suggesting that Caco-2 monolayers almost completely block the permeation of BaP and its metabolites (30) . Previous studies demonstrated that Caco-2 cells could metabolise BaP primarily into BaP-1-and BaP-3-sulfates, which then undergo apically directed transport (31, 32) . One study has shown that the breast cancer resistance protein (BCRP) is involved in the apically directed transport of phase-2 metabolites of BaP in Caco-2 cells (25) . The intestinal barrier is thus a crucial epithelium that protects the whole body from exposure to food contaminants (25) . In another co-culture system with Caco-2 and HepG2 cells, the concentrations of BaP and its metabolites on the BL side were too low to induce any toxicity in HepG2 cells (30) . All these results demonstrate that Caco-2 cells may be responsible for first-pass metabolism, which may lead to a decrease in the bioavailability of ingested compounds.
In our study, BaP biotransformation and transport of metabolites to the AP side of Caco-2 cells prevented systemic toxicity, as indicated by the absence of cytotoxicity and genotoxicity in the TK6 cells as previously described in mice (33) . Even if intestinal cells effectively protected the systemic toxicity of BaP, genotoxic effects were still observed in Caco-2 cells. This data is consistent with the carcinogenic potential of this compound in the intestine (34) .
In this study, we also showed micronucleus formation after treatment with the mycotoxin AFB1 at 0.5 µM on differentiated Caco-2 cells, as previously demonstrated on undifferentiated Caco-2 cells (15) . Our results demonstrate that differentiated Caco-2 cells are able to metabolise AFB1 into genotoxic metabolites. CYP1A2 and 3A4 are the main CYP450 isoforms for AFB1 activation into the genotoxic metabolite aflatoxin-exo-7-8-epoxyde (35, 36) . CYP3A4 expression in Caco-2 cells is controversial. Although there are some reports of CYP3A4 expression in Caco-2 cells, CYP3A4 levels in Caco-2 cells are low compared with that in hepatocytes or the human intestine. CYP3A4 expression has been induced with 1,25-vitD3 (37) (38) (39) . Similarly, the levels of CYP34A mRNA can increase 200-to 500-fold by adding 100 nM vitD3 for 2 weeks (39). In any case, the specific Caco-2 clone and cell culture conditions used may explain the discrepancies in CYP3A4 expression reported in the literature for this cell line (39) .
In this study, AFB1 induced a dose-dependent increase of micronuclei both in Caco-2 and TK6 cells, suggesting that intestinal cells play a role in the bioactivation of AFB1. The generated metabolites induced DNA damage not only at the site of production (i.e. Caco-2 cells) but also in the TK6 cells seeded on the BL side, indicating potential blood and systemic exposure to genotoxic AFB1 metabolites after AFB1 ingestion. However the bioactivation of AFB1 by extrahepatic tissue, such as the intestine, has been considered to protect against AFB1 carcinogenicity potential by reducing the systemic distribution of AFB1 (40) . Even though, it could not be totally excluded that AFB1 could be mutagenic in vivo on intestinal epithelium, addition of the CYP3A4 inhibitor ketoconazole completely prevents AFB1 cytotoxicity and genotoxicity in TK6 cells, suggesting the crucial role of intestinal metabolism, in particular CYP3A4 activity, in the genotoxicity of AFB1 for enterocyte cells and all organs after systemic exposure. These results are consistent with previous work, which shows that P450 3A4 expression is the most important determinant of AFB1 bioactivation (41) .
Taken together, these results showed that our Caco-2/TK6 co-culture system can be used as a surrogate model to study the role of the intestinal first-pass metabolism and transport in the genotoxic responses of oral drugs. Our co-culture system thereby contributes to the development of new in vitro models that help increase predictivity in genotoxicology.
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